Cancer Pain – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Cancer Pain - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
$ 2000
|
|
|
Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. T
|
$ 2000
|
|
|
TechNavio''s analysts forecast the Global Kidney Cancer Drugs market to grow at a CAGR of 13.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing demand in developing economies. The Global Kidne
|
$ 2000
|
|
|
TechNavio''s analysts forecast the Global Next-generation Cancer Diagnostic Devices market to grow at a CAGR of 48.11 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer.
|
$ 2000
|
|
|
This new report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current a...
|
$ 19700
|
|
|
Global Markets Direct’s, 'Colon Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Colon Cancer, complete with la...
|
$ 2000
|
|
|
Global Markets Direct’s, 'Metastatic Colorectal Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Col...
|
$ 2000
|
|
|
Global Markets Direct’s, 'Small-Cell Lung Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Small-Cell Lung Canc...
|
$ 2000
|
|
|
Global Markets Direct’s, 'Metastatic Pancreatic Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Pan...
|
$ 2000
|
|
|
Global Markets Direct’s, 'Liver Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with la...
|
$ 2000
|
|
|
Global Markets Direct’s, 'Fallopian Tube Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Fallopian Tube Cancer...
|
$ 2000
|
|
|
Global Markets Direct’s, 'Endometrial Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Endometrial Cancer, comp...
|
$ 2000
|
|
|
Global Markets Direct’s, 'Brain Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Brain Cancer, complete with la...
|
$ 2000
|
|
|
Global Markets Direct’s, 'Peritoneal Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Peritoneal Cancer, comple...
|
$ 2000
|
|
|
Global Markets Direct’s, 'Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...
|
$ 2000
|
|
|
Global Markets Direct’s, 'Rectal Cancer Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Rectal Cancer, complete with ...
|
$ 2000
|
|
|
Nasopharyngeal Cancer – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Nasopharyngeal Cancer - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therape
|
$ 2000
|
|
|
Epithelial Ovarian Cancer – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Epithelial Ovarian Cancer - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the
|
$ 2000
|
|
|
Transitional Cell Cancer (Urothelial Cell Cancer) – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic p
|
$ 2000
|
|
|
Squamous Non-Small Cell Lung Cancer – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provide
|
$ 2000
|
|
|